Show items per page
Elements: 22
Page 1 on 2
 TitleAuthors / EditorsDate
add to browser selection
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease Nordberg, Agneta; Carter, Stephen F; Rinne, Juha; Drzezga, Alexander; ... Herholz, Karl 2013
add to browser selection
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias Chételat, Gaël; Arbizu, Javier; Barthel, Henryk; Garibotto, Valentina; ... Drzezga, Alexander 2020
add to browser selection
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders Nobili, Flavio; Festari, Cristina; Altomare, Daniele; Agosta, Federica; ... Boccardi, Marina 2018
add to browser selection
Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia Walker, Zuzana; Gandolfo, Federica; Orini, Stefania; Garibotto, Valentina; ... Nobili, Flavio 2018
add to browser selection
Clinical utility of FDG-PET for the clinical diagnosis in MCI Arbizu, Javier; Festari, Cristina; Altomare, Daniele; Walker, Zuzana; ... Nobili, Flavio 2018
add to browser selection
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia Nestor, Peter J; Altomare, Daniele; Festari, Cristina; Drzezga, Alexander; ... Frisoni, Giovanni 2018
add to browser selection
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease Agosta, Federica; Altomare, Daniele; Festari, Cristina; Orini, Stefania; ... Pagani, Marco 2018
add to browser selection
Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework Chiotis, Konstantinos; Dodich, Alessandra; Boccardi, Marina; Festari, Cristina; ... Nordberg, Agneta 2021
add to browser selection
Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework Bischof, Gérard N; Dodich, Alessandra; Boccardi, Marina; van Eimeren, Thilo; ... Drzezga, Alexander 2021
add to browser selection
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease Drzezga, Alexander; Altomare, Daniele; Festari, Cristina; Arbizu, Javier; ... Boccardi, Marina 2018
add to browser selection
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia Bouwman, Femke; Orini, Stefania; Gandolfo, Federica; Altomare, Daniele; ... Boccardi, Marina 2018
add to browser selection
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0 Morbelli, Silvia; Esposito, Giuseppe; Arbizu, Javier; Barthel, Henryk; ... Law, Ian 2020
add to browser selection
Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis Morbelli, Silvia; Arbizu, Javier; Booij, Jan; Chen, Ming-Kai; ... Barthel, Henryk 2017
add to browser selection
Finding our way through the labyrinth of dementia biomarkers Chételat, Gaël; Arbizu, Javier; Barthel, Henryk; Garibotto, Valentina; ... Drzezga, Alexander 2021
add to browser selection
Head-to-head comparison among semi-quantification tools of brain FDG-PET to aid the diagnosis of prodromal Alzheimer's disease Brugnolo, Andrea; De Carli, Fabrizio; Pagani, Marco; Morbelli, Slivia; ... Nobili, Flavio 2019
add to browser selection
Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression Caroli, Anna; Prestia, Annapaola; Galluzzi, Samantha; Ferrari, Clarissa; ... Frisoni, Giovanni 2015
add to browser selection
Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection Teipel, Stefan; Drzezga, Alexander; Grothe, Michel J; Barthel, Henryk; ... Fellgiebel, Andreas 2015
add to browser selection
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset Altomare, Daniele; Ferrari, Clarissa; Caroli, Anna; Galluzzi, Samantha; ... Frisoni, Giovanni 2019
add to browser selection
Proven validity and management impact of amyloid imaging in Alzheimer's disease-repetita juvant Barthel, Henryk; Arbizu, Javier; Drzezga, Alexander; Garibotto, Valentina; ... Morbelli, Silvia 2020
add to browser selection
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study Lopes Alves, Isadora; Collij, Lyduine E; Altomare, Daniele; Frisoni, Giovanni; ... Molinuevo, José Luis 2020
<< previous | 1 | 2 |